CLINICAL_TRIALS
trial_result
· 2015-08-21
Clinical Trial Update: Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation [Phase 1]
Summary
Phase 1 trial evaluating dosage form proportionality of the opicapone to-be-marketed formulation; the study in epilepsy completed with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2015-08-21